Tenet Healthcare Corporation
THC | NYSE
$260.97
-$1.02 (-0.39%)
At close: Sep 21, 2026, 4:00 PM ET
$260.97
$0 (0.00%)
After-hours:
Sep 21, 2026, 5:55 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 21.31B | 20.67B | 20.55B | 19.17B | 19.49B | 17.64B |
Cost of Revenue | 3.78B | 12.46B | 12.74B | 12.13B | 12.22B | 11.41B |
Gross Profit | 17.53B | 8.21B | 7.81B | 7.05B | 7.27B | 6.23B |
Operating Income | 3.44B | 5.96B | 2.51B | 2.33B | 2.87B | 1.99B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 2.8B | 5.25B | 1.62B | 1.35B | 1.89B | 671M |
Net Income | 1.41B | 3.2B | 611M | 411M | 914M | 399M |
Selling & General & Admin | 8.71B | 8.8B | 418M | 412M | 412M | 403M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 5.39B | -6.55B | 4.88B | 4.3B | 3.99B | 3.84B |
Operating Expenses | 14.09B | 2.25B | 5.3B | 4.72B | 4.4B | 4.24B |
Interest Expense | 821M | 826M | 901M | 890M | 923M | 1B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.87B | 14.71B | 18.04B | 16.84B | 16.61B | 15.65B |
Income Tax Expense | 433M | 1.18B | 306M | 344M | 411M | -97M |
Shares Outstanding (Basic) | 90.15M | 96.9M | 101.64M | 106.93M | 106.83M | 105.01M |
Shares Outstanding (Diluted) | 90.83M | 97.88M | 104.8M | 110.52M | 108.57M | 106.26M |
EPS (Basic) | 15.61 | 33.02 | 6.01 | 3.84 | 8.55 | 3.80 |
EPS (Diluted) | 15.49 | 32.70 | 5.71 | 3.79 | 8.42 | 3.75 |
EBITDA | 4.48B | 6.89B | 3.39B | 3.08B | 3.67B | 2.53B |
EBIT | 3.62B | 6.07B | 2.52B | 2.24B | 2.81B | 1.67B |
Depreciation & Amortization | 863M | 818M | 870M | 841M | 855M | 857M |
Add to Watchlist
Select watchlists to add or remove THC